接受活性抗肿瘤治疗患者对 SARS-CoV-2 BNT162b2 疫苗接种的反应持久性。
Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment.
机构信息
Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
出版信息
JAMA Oncol. 2021 Nov 1;7(11):1716-1718. doi: 10.1001/jamaoncol.2021.4390.
Abstract
This cohort study examines the durability of immune response from BNT162b2 vaccination for severe acute respiratory syndrome coronavirus 2 in patients with cancer vs healthy controls.
摘要
这项队列研究考察了 BNT162b2 疫苗接种对癌症患者与健康对照者严重急性呼吸综合征冠状病毒 2 免疫反应的持久性。
Zotero 插件